Beta-2 receptor study in healthy men
Part of Hormones & metabolism clinical trials.
This trial tests how beta-2 receptors work in your muscles. It's designed for healthy men and may help understand how these receptors affect your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 21 and 45 years old
- Your body mass index (BMI) is between 25 and 35
- Your body fat percentage is between 25% and 40%
- Your lean mass index is between 14 and 22
- You are not a current smoker
- You do not have any major health conditions like heart, lung, or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a medicine (beta-2 agonist) combined with extra amino acids (building blocks of protein) affects muscle growth. It looks at how your body builds new muscle in response to these two things together.
This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This trial tests how beta-blockers affect your body's reaction to stress. You'll take a beta-blocker or placebo and then do a stress task, so researchers can measure inflammation and other responses.
Hear when a new Overweight and Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.